학술논문
First-line trastuzumab plus epirubicin and cyclophosphamide therapy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: Cardiac safety and efficacy data from the herceptin, cyclophosphamide, and epirubicin (HERCULES) trial
Document Type
Article
Author
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 20 March 2010, 28(9):1473-1480)
Subject
Language
English
ISSN
0732183X
15277755
15277755